Showing results (181-190 of 287) with videos related to

Sort By:
Pageof 29
Psychiatric Genetics|July 1, 1997
Ciliary neurotrophic factor null mutation and schizophrenia in a Swedish populationJ Thome, E Jönsson, P Foley, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1984
Time course for effects of sulpiride and chlorpromazine on monoamine metabolite and prolactin levels in cerebrospinal fluid from schizophrenic patientsC Härnryd, L Bjerkenstedt, B Gullberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 26, 1998
Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in manL Farde, H Ito, C G Swahn, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 1, 1994
Selective synthesis of racemic 1-11C-labelled norepinephrine, octopamine, norphenylephrine and phenylethanolamine using [11C]nitromethaneK Någren, K O Schoeps, C Halldin, et al.
Brain : a Journal of Neurology|February 4, 1998
Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumesL Bäckman, T B Robins-Wahlin, A Lundin, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 2, 2004
Transcription factor AP-2beta genotype, striatal dopamine D2 receptor density and cerebrospinal fluid monoamine metabolite concentrations in humansM Damberg, C Berggård, L Farde, et al.
Neurology|April 28, 2004
Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsyI Savic, P Lindström, B Gulyás, et al.
Synapse (New York, N.Y.)|February 1, 1994
PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brainL Farde, C Halldin, L Müller, et al.
Pageof 29